HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-NOV-18 6N3L TITLE IDENTIFICATION OF NOVEL, POTENT AND SELECTIVE GCN2 INHIBITORS AS TITLE 2 FIRST-IN-CLASS ANTI-TUMOR AGENTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: EIF-2-ALPHA KINASE GCN2,EIF-2-ALPHA KINASE GCN2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4, COMPND 5 GCN2-LIKE PROTEIN,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA COMPND 6 KINASE 4,GCN2-LIKE PROTEIN; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EIF2AK4, GCN2, KIAA1338; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS GCN2, KINASE, INHIBITOR, ANTI-TUMOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.D.HOFFMAN,J.FUJIMOTO,O.KURASAWA,T.TAKAGI,M.G.KLEIN,G.KEFALA, AUTHOR 2 S.C.DING,D.R.CARY,R.MIZOJIRI REVDAT 3 13-MAR-24 6N3L 1 REMARK REVDAT 2 30-OCT-19 6N3L 1 JRNL REVDAT 1 09-OCT-19 6N3L 0 JRNL AUTH J.FUJIMOTO,O.KURASAWA,T.TAKAGI,X.LIU,H.BANNO,T.KOJIMA, JRNL AUTH 2 Y.ASANO,A.NAKAMURA,T.NAMBU,A.HATA,T.ISHII,T.SAMESHIMA, JRNL AUTH 3 Y.DEBORI,M.MIYAMOTO,M.G.KLEIN,R.TJHEN,B.C.SANG,I.LEVIN, JRNL AUTH 4 S.W.LANE,G.P.SNELL,K.LI,G.KEFALA,I.D.HOFFMAN,S.C.DING, JRNL AUTH 5 D.R.CARY,R.MIZOJIRI JRNL TITL IDENTIFICATION OF NOVEL, POTENT, AND ORALLY AVAILABLE GCN2 JRNL TITL 2 INHIBITORS WITH TYPE I HALF BINDING MODE. JRNL REF ACS MED.CHEM.LETT. V. 10 1498 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31620240 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00400 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 17799 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3802 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.76000 REMARK 3 B22 (A**2) : 0.49000 REMARK 3 B33 (A**2) : -2.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.817 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.364 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.340 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 37.065 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6N3L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000238122. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97648 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36200 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.86000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS 8.5, 24% PEG3350, 450 MM REMARK 280 NAFORMATE, 1% HEXANEDIOL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.33700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.33700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.94300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.11650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 41.94300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.11650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 60.33700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.94300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 61.11650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 60.33700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 41.94300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 61.11650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 561 REMARK 465 HIS A 562 REMARK 465 HIS A 563 REMARK 465 HIS A 564 REMARK 465 HIS A 565 REMARK 465 HIS A 566 REMARK 465 HIS A 567 REMARK 465 GLU A 568 REMARK 465 ASN A 569 REMARK 465 LEU A 570 REMARK 465 TYR A 571 REMARK 465 PHE A 572 REMARK 465 GLN A 573 REMARK 465 GLY A 574 REMARK 465 GLY A 575 REMARK 465 SER A 576 REMARK 465 SER A 577 REMARK 465 GLU A 578 REMARK 465 THR A 579 REMARK 465 GLN A 580 REMARK 465 ARG A 581 REMARK 465 GLN A 582 REMARK 465 PHE A 583 REMARK 465 GLY A 782 REMARK 465 CYS A 783 REMARK 465 HIS A 784 REMARK 465 GLU A 785 REMARK 465 SER A 786 REMARK 465 GLU A 787 REMARK 465 PRO A 788 REMARK 465 SER A 789 REMARK 465 VAL A 790 REMARK 465 THR A 791 REMARK 465 THR A 792 REMARK 465 GLU A 793 REMARK 465 ALA A 794 REMARK 465 GLY A 868 REMARK 465 LEU A 869 REMARK 465 ALA A 870 REMARK 465 THR A 871 REMARK 465 ASP A 872 REMARK 465 HIS A 873 REMARK 465 LEU A 874 REMARK 465 ALA A 875 REMARK 465 PHE A 876 REMARK 465 SER A 877 REMARK 465 ALA A 878 REMARK 465 ASP A 879 REMARK 465 SER A 880 REMARK 465 LYS A 881 REMARK 465 GLN A 882 REMARK 465 ASP A 883 REMARK 465 ASP A 884 REMARK 465 GLN A 885 REMARK 465 THR A 886 REMARK 465 GLY A 887 REMARK 465 ASP A 888 REMARK 465 LEU A 889 REMARK 465 ILE A 890 REMARK 465 LYS A 891 REMARK 465 SER A 892 REMARK 465 ASP A 893 REMARK 465 PRO A 894 REMARK 465 SER A 895 REMARK 465 GLY A 896 REMARK 465 HIS A 897 REMARK 465 LEU A 898 REMARK 465 ALA A 899 REMARK 465 GLY A 900 REMARK 465 MET A 901 REMARK 465 VAL A 902 REMARK 465 GLY A 903 REMARK 465 VAL A 912 REMARK 465 GLN A 913 REMARK 465 GLY A 914 REMARK 465 SER A 915 REMARK 465 THR A 916 REMARK 465 LYS A 917 REMARK 465 SER A 918 REMARK 465 ALA A 919 REMARK 465 THR A 958 REMARK 465 SER A 959 REMARK 465 PRO A 960 REMARK 465 LYS A 961 REMARK 465 ASP A 967 REMARK 465 ASP A 968 REMARK 465 GLY A 969 REMARK 465 GLU A 970 REMARK 465 PRO A 1003 REMARK 465 PRO A 1004 REMARK 465 GLN A 1005 REMARK 465 MET A 1006 REMARK 465 GLU A 1007 REMARK 465 GLU A 1008 REMARK 465 SER A 1009 REMARK 465 GLU A 1010 REMARK 465 LEU A 1011 REMARK 465 HIS A 1012 REMARK 465 GLU A 1013 REMARK 465 MET B 561 REMARK 465 HIS B 562 REMARK 465 HIS B 563 REMARK 465 HIS B 564 REMARK 465 HIS B 565 REMARK 465 HIS B 566 REMARK 465 HIS B 567 REMARK 465 GLU B 568 REMARK 465 ASN B 569 REMARK 465 LEU B 570 REMARK 465 TYR B 571 REMARK 465 PHE B 572 REMARK 465 GLN B 573 REMARK 465 GLY B 574 REMARK 465 GLY B 575 REMARK 465 SER B 576 REMARK 465 SER B 577 REMARK 465 GLU B 578 REMARK 465 THR B 579 REMARK 465 GLN B 580 REMARK 465 ARG B 581 REMARK 465 GLN B 582 REMARK 465 PHE B 583 REMARK 465 ASN B 624 REMARK 465 PRO B 625 REMARK 465 ASN B 781 REMARK 465 GLY B 782 REMARK 465 CYS B 783 REMARK 465 HIS B 784 REMARK 465 GLU B 785 REMARK 465 SER B 786 REMARK 465 GLU B 787 REMARK 465 PRO B 788 REMARK 465 SER B 789 REMARK 465 VAL B 790 REMARK 465 THR B 791 REMARK 465 THR B 792 REMARK 465 GLU B 793 REMARK 465 ALA B 794 REMARK 465 VAL B 795 REMARK 465 GLY B 868 REMARK 465 LEU B 869 REMARK 465 ALA B 870 REMARK 465 THR B 871 REMARK 465 ASP B 872 REMARK 465 HIS B 873 REMARK 465 LEU B 874 REMARK 465 ALA B 875 REMARK 465 PHE B 876 REMARK 465 SER B 877 REMARK 465 ALA B 878 REMARK 465 ASP B 879 REMARK 465 SER B 880 REMARK 465 LYS B 881 REMARK 465 GLN B 882 REMARK 465 ASP B 883 REMARK 465 ASP B 884 REMARK 465 GLN B 885 REMARK 465 THR B 886 REMARK 465 GLY B 887 REMARK 465 ASP B 888 REMARK 465 LEU B 889 REMARK 465 ILE B 890 REMARK 465 LYS B 891 REMARK 465 SER B 892 REMARK 465 ASP B 893 REMARK 465 PRO B 894 REMARK 465 SER B 895 REMARK 465 GLY B 896 REMARK 465 HIS B 897 REMARK 465 LEU B 898 REMARK 465 ALA B 899 REMARK 465 GLY B 900 REMARK 465 MET B 901 REMARK 465 VAL B 902 REMARK 465 GLY B 903 REMARK 465 VAL B 912 REMARK 465 GLN B 913 REMARK 465 GLY B 914 REMARK 465 SER B 915 REMARK 465 THR B 916 REMARK 465 LYS B 917 REMARK 465 SER B 918 REMARK 465 ALA B 919 REMARK 465 THR B 958 REMARK 465 SER B 959 REMARK 465 PRO B 960 REMARK 465 LYS B 961 REMARK 465 ASP B 967 REMARK 465 ASP B 968 REMARK 465 GLY B 969 REMARK 465 GLU B 970 REMARK 465 PRO B 1003 REMARK 465 PRO B 1004 REMARK 465 GLN B 1005 REMARK 465 MET B 1006 REMARK 465 GLU B 1007 REMARK 465 GLU B 1008 REMARK 465 SER B 1009 REMARK 465 GLU B 1010 REMARK 465 LEU B 1011 REMARK 465 HIS B 1012 REMARK 465 GLU B 1013 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 593 -58.26 -123.42 REMARK 500 PRO A 625 152.29 -38.10 REMARK 500 ALA A 626 29.28 47.13 REMARK 500 ALA A 807 -156.84 -77.05 REMARK 500 ARG A 847 -15.53 81.80 REMARK 500 ASN A 848 29.49 -143.46 REMARK 500 ASP A 956 -163.77 -175.12 REMARK 500 ALA B 807 -153.01 -78.42 REMARK 500 ARG B 847 -20.28 83.50 REMARK 500 PRO B 910 -100.59 -39.37 REMARK 500 ASP B 956 -155.21 -178.79 REMARK 500 GLU B 999 44.39 -103.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 920 ASN A 921 -147.40 REMARK 500 ASP A 956 PRO A 957 148.67 REMARK 500 TYR B 920 ASN B 921 -126.68 REMARK 500 ASP B 956 PRO B 957 144.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KAV A 2501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KAV B 2501 DBREF 6N3L A 577 657 UNP Q9P2K8 E2AK4_HUMAN 577 657 DBREF 6N3L A 782 1013 UNP Q9P2K8 E2AK4_HUMAN 782 1013 DBREF 6N3L B 577 657 UNP Q9P2K8 E2AK4_HUMAN 577 657 DBREF 6N3L B 782 1013 UNP Q9P2K8 E2AK4_HUMAN 782 1013 SEQADV 6N3L MET A 561 UNP Q9P2K8 INITIATING METHIONINE SEQADV 6N3L HIS A 562 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS A 563 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS A 564 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS A 565 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS A 566 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS A 567 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLU A 568 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L ASN A 569 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L LEU A 570 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L TYR A 571 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L PHE A 572 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLN A 573 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLY A 574 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLY A 575 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L SER A 576 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L ASN A 658 UNP Q9P2K8 LINKER SEQADV 6N3L ALA A 807 UNP Q9P2K8 LYS 807 ENGINEERED MUTATION SEQADV 6N3L ASN A 848 UNP Q9P2K8 ASP 848 ENGINEERED MUTATION SEQADV 6N3L ALA A 899 UNP Q9P2K8 THR 899 ENGINEERED MUTATION SEQADV 6N3L ALA A 904 UNP Q9P2K8 THR 904 ENGINEERED MUTATION SEQADV 6N3L MET B 561 UNP Q9P2K8 INITIATING METHIONINE SEQADV 6N3L HIS B 562 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS B 563 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS B 564 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS B 565 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS B 566 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L HIS B 567 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLU B 568 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L ASN B 569 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L LEU B 570 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L TYR B 571 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L PHE B 572 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLN B 573 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLY B 574 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L GLY B 575 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L SER B 576 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3L ASN B 781 UNP Q9P2K8 LINKER SEQADV 6N3L ALA B 807 UNP Q9P2K8 LYS 807 ENGINEERED MUTATION SEQADV 6N3L ASN B 848 UNP Q9P2K8 ASP 848 ENGINEERED MUTATION SEQADV 6N3L ALA B 899 UNP Q9P2K8 THR 899 ENGINEERED MUTATION SEQADV 6N3L ALA B 904 UNP Q9P2K8 THR 904 ENGINEERED MUTATION SEQRES 1 A 330 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SEQRES 2 A 330 GLY GLY SER SER GLU THR GLN ARG GLN PHE SER ARG TYR SEQRES 3 A 330 PHE ILE GLU PHE GLU GLU LEU GLN LEU LEU GLY LYS GLY SEQRES 4 A 330 ALA PHE GLY ALA VAL ILE LYS VAL GLN ASN LYS LEU ASP SEQRES 5 A 330 GLY CYS CYS TYR ALA VAL LYS ARG ILE PRO ILE ASN PRO SEQRES 6 A 330 ALA SER ARG GLN PHE ARG ARG ILE LYS GLY GLU VAL THR SEQRES 7 A 330 LEU LEU SER ARG LEU HIS HIS GLU ASN ILE VAL ARG TYR SEQRES 8 A 330 TYR ASN ALA TRP ILE GLU ASN GLY CYS HIS GLU SER GLU SEQRES 9 A 330 PRO SER VAL THR THR GLU ALA VAL HIS TYR LEU TYR ILE SEQRES 10 A 330 GLN MET GLU TYR CYS GLU ALA SER THR LEU ARG ASP THR SEQRES 11 A 330 ILE ASP GLN GLY LEU TYR ARG ASP THR VAL ARG LEU TRP SEQRES 12 A 330 ARG LEU PHE ARG GLU ILE LEU ASP GLY LEU ALA TYR ILE SEQRES 13 A 330 HIS GLU LYS GLY MET ILE HIS ARG ASN LEU LYS PRO VAL SEQRES 14 A 330 ASN ILE PHE LEU ASP SER ASP ASP HIS VAL LYS ILE GLY SEQRES 15 A 330 ASP PHE GLY LEU ALA THR ASP HIS LEU ALA PHE SER ALA SEQRES 16 A 330 ASP SER LYS GLN ASP ASP GLN THR GLY ASP LEU ILE LYS SEQRES 17 A 330 SER ASP PRO SER GLY HIS LEU ALA GLY MET VAL GLY ALA SEQRES 18 A 330 ALA LEU TYR VAL SER PRO GLU VAL GLN GLY SER THR LYS SEQRES 19 A 330 SER ALA TYR ASN GLN LYS VAL ASP LEU PHE SER LEU GLY SEQRES 20 A 330 ILE ILE PHE PHE GLU MET SER TYR HIS PRO MET VAL THR SEQRES 21 A 330 ALA SER GLU ARG ILE PHE VAL LEU ASN GLN LEU ARG ASP SEQRES 22 A 330 PRO THR SER PRO LYS PHE PRO GLU ASP PHE ASP ASP GLY SEQRES 23 A 330 GLU HIS ALA LYS GLN LYS SER VAL ILE SER TRP LEU LEU SEQRES 24 A 330 ASN HIS ASP PRO ALA LYS ARG PRO THR ALA THR GLU LEU SEQRES 25 A 330 LEU LYS SER GLU LEU LEU PRO PRO PRO GLN MET GLU GLU SEQRES 26 A 330 SER GLU LEU HIS GLU SEQRES 1 B 330 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SEQRES 2 B 330 GLY GLY SER SER GLU THR GLN ARG GLN PHE SER ARG TYR SEQRES 3 B 330 PHE ILE GLU PHE GLU GLU LEU GLN LEU LEU GLY LYS GLY SEQRES 4 B 330 ALA PHE GLY ALA VAL ILE LYS VAL GLN ASN LYS LEU ASP SEQRES 5 B 330 GLY CYS CYS TYR ALA VAL LYS ARG ILE PRO ILE ASN PRO SEQRES 6 B 330 ALA SER ARG GLN PHE ARG ARG ILE LYS GLY GLU VAL THR SEQRES 7 B 330 LEU LEU SER ARG LEU HIS HIS GLU ASN ILE VAL ARG TYR SEQRES 8 B 330 TYR ASN ALA TRP ILE GLU ASN GLY CYS HIS GLU SER GLU SEQRES 9 B 330 PRO SER VAL THR THR GLU ALA VAL HIS TYR LEU TYR ILE SEQRES 10 B 330 GLN MET GLU TYR CYS GLU ALA SER THR LEU ARG ASP THR SEQRES 11 B 330 ILE ASP GLN GLY LEU TYR ARG ASP THR VAL ARG LEU TRP SEQRES 12 B 330 ARG LEU PHE ARG GLU ILE LEU ASP GLY LEU ALA TYR ILE SEQRES 13 B 330 HIS GLU LYS GLY MET ILE HIS ARG ASN LEU LYS PRO VAL SEQRES 14 B 330 ASN ILE PHE LEU ASP SER ASP ASP HIS VAL LYS ILE GLY SEQRES 15 B 330 ASP PHE GLY LEU ALA THR ASP HIS LEU ALA PHE SER ALA SEQRES 16 B 330 ASP SER LYS GLN ASP ASP GLN THR GLY ASP LEU ILE LYS SEQRES 17 B 330 SER ASP PRO SER GLY HIS LEU ALA GLY MET VAL GLY ALA SEQRES 18 B 330 ALA LEU TYR VAL SER PRO GLU VAL GLN GLY SER THR LYS SEQRES 19 B 330 SER ALA TYR ASN GLN LYS VAL ASP LEU PHE SER LEU GLY SEQRES 20 B 330 ILE ILE PHE PHE GLU MET SER TYR HIS PRO MET VAL THR SEQRES 21 B 330 ALA SER GLU ARG ILE PHE VAL LEU ASN GLN LEU ARG ASP SEQRES 22 B 330 PRO THR SER PRO LYS PHE PRO GLU ASP PHE ASP ASP GLY SEQRES 23 B 330 GLU HIS ALA LYS GLN LYS SER VAL ILE SER TRP LEU LEU SEQRES 24 B 330 ASN HIS ASP PRO ALA LYS ARG PRO THR ALA THR GLU LEU SEQRES 25 B 330 LEU LYS SER GLU LEU LEU PRO PRO PRO GLN MET GLU GLU SEQRES 26 B 330 SER GLU LEU HIS GLU HET KAV A2501 34 HET KAV B2501 34 HETNAM KAV N-{6-[(1-METHYL-2-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}- HETNAM 2 KAV 1H-BENZIMIDAZOL-5-YL)OXY]PYRIMIDIN-4- HETNAM 3 KAV YL}CYCLOPROPANECARBOXAMIDE FORMUL 3 KAV 2(C23 H19 F3 N6 O2) FORMUL 5 HOH *48(H2 O) HELIX 1 AA1 SER A 584 GLU A 589 1 6 HELIX 2 AA2 SER A 627 SER A 641 1 15 HELIX 3 AA3 THR A 809 GLN A 816 1 8 HELIX 4 AA4 GLY A 817 ARG A 820 5 4 HELIX 5 AA5 ASP A 821 LYS A 842 1 22 HELIX 6 AA6 LYS A 850 VAL A 852 5 3 HELIX 7 AA7 ALA A 904 VAL A 908 5 5 HELIX 8 AA8 LYS A 923 TYR A 938 1 16 HELIX 9 AA9 THR A 943 GLN A 953 1 11 HELIX 10 AB1 ALA A 972 LEU A 982 1 11 HELIX 11 AB2 ASP A 985 ARG A 989 5 5 HELIX 12 AB3 THR A 991 SER A 998 1 8 HELIX 13 AB4 ARG B 585 GLU B 589 1 5 HELIX 14 AB5 SER B 627 SER B 641 1 15 HELIX 15 AB6 THR B 809 GLN B 816 1 8 HELIX 16 AB7 GLY B 817 ARG B 820 5 4 HELIX 17 AB8 ASP B 821 LYS B 842 1 22 HELIX 18 AB9 LYS B 850 VAL B 852 5 3 HELIX 19 AC1 ALA B 904 VAL B 908 5 5 HELIX 20 AC2 LYS B 923 TYR B 938 1 16 HELIX 21 AC3 THR B 943 GLN B 953 1 11 HELIX 22 AC4 ALA B 972 LEU B 982 1 11 HELIX 23 AC5 ASP B 985 ARG B 989 5 5 HELIX 24 AC6 THR B 991 SER B 998 1 8 SHEET 1 AA1 5 PHE A 590 GLY A 599 0 SHEET 2 AA1 5 GLY A 602 ASN A 609 -1 O VAL A 604 N LEU A 596 SHEET 3 AA1 5 CYS A 615 PRO A 622 -1 O ARG A 620 N ALA A 603 SHEET 4 AA1 5 TYR A 797 GLU A 803 -1 O LEU A 798 N ILE A 621 SHEET 5 AA1 5 TYR A 651 GLU A 657 -1 N ASN A 653 O GLN A 801 SHEET 1 AA2 2 ILE A 854 LEU A 856 0 SHEET 2 AA2 2 VAL A 862 ILE A 864 -1 O LYS A 863 N PHE A 855 SHEET 1 AA3 5 PHE B 590 LYS B 598 0 SHEET 2 AA3 5 ALA B 603 ASN B 609 -1 O LYS B 606 N LEU B 593 SHEET 3 AA3 5 CYS B 615 PRO B 622 -1 O ARG B 620 N ALA B 603 SHEET 4 AA3 5 TYR B 797 GLU B 803 -1 O LEU B 798 N ILE B 621 SHEET 5 AA3 5 TYR B 651 ILE B 656 -1 N ASN B 653 O GLN B 801 SHEET 1 AA4 2 ILE B 854 LEU B 856 0 SHEET 2 AA4 2 VAL B 862 ILE B 864 -1 O LYS B 863 N PHE B 855 SITE 1 AC1 19 LEU A 596 VAL A 604 ALA A 617 LYS A 619 SITE 2 AC1 19 GLU A 636 LEU A 640 LEU A 643 MET A 802 SITE 3 AC1 19 GLU A 803 TYR A 804 CYS A 805 ALA A 807 SITE 4 AC1 19 MET A 844 HIS A 846 PHE A 855 ILE A 864 SITE 5 AC1 19 GLY A 865 ASP A 866 PHE A 867 SITE 1 AC2 21 LEU B 596 VAL B 604 ALA B 617 LYS B 619 SITE 2 AC2 21 GLU B 636 LEU B 640 LEU B 643 ILE B 648 SITE 3 AC2 21 VAL B 649 MET B 802 GLU B 803 TYR B 804 SITE 4 AC2 21 CYS B 805 ILE B 839 MET B 844 HIS B 846 SITE 5 AC2 21 PHE B 855 ILE B 864 GLY B 865 ASP B 866 SITE 6 AC2 21 PHE B 867 CRYST1 83.886 122.233 120.674 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011921 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008181 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008287 0.00000